Suchergebnisse - "184SNS8VUH"

PubPharm (1.400)

101

Effects of FMO3 Polymorphisms on Pharmacokinetics of Sulindac in Chinese Healthy Male Volunteers

enthalten in: BioMed research international | 2017

von Tang, Y. | Hu, K. | Huang, W. | +7

102

Activation of Protein Kinase G (PKG) Reduces Neointimal Hyperplasia, Inhibits Platelet Aggregation, and Facilitates Re-endothelialization

enthalten in: Scientific reports | 2016

von Kim, J. | Yang, H. | Lee, J. | +11

103

NSAID-activated gene 1 mediates pro-inflammatory signaling activation and paclitaxel chemoresistance in type I human epithelial ovarian cancer stem-like cells

enthalten in: Oncotarget | 2016

von Kim, K. | Park, S. | Do, K. | +3

104

Mebendazole and a non-steroidal anti-inflammatory combine to reduce tumor initiation in a colon cancer preclinical model

enthalten in: Oncotarget | 2016

von Williamson, T. | Bai, R. | Staedtke, V. | +2

105

Combined treatment with vitamin C and sulindac synergistically induces p53- and ROS-dependent apoptosis in human colon cancer cells

enthalten in: Toxicology letters | 2016

von Gong, E. | Shin, Y. | Hwang, I. | +10

106

Celecoxib and sulindac inhibit TGF-β1-induced epithelial-mesenchymal transition and suppress lung cancer migration and invasion via downregulation of sirtuin 1

enthalten in: Oncotarget | 2016

von Cha, B. | Kim, Y. | Hwang, K. | +7

107

Efficacy and safety of eflornithine (CPP-1X)/sulindac combination therapy versus each as monotherapy in patients with familial adenomatous polyposis (FAP) : design and rationale of a randomized, double-blind, Phase III trial

enthalten in: BMC gastroenterology | 2016

von Burke, C. | Dekker, E. | Samadder, N. | +2

108

Chemoprevention of familial adenomatous polyposis

enthalten in: Familial cancer | 2016

von Lynch, P.

109

Wnt-beta-catenin pathway signals metastasis-associated tumor cell phenotypes in triple negative breast cancers

enthalten in: Oncotarget | 2016

von De, P. | Carlson, J. | Wu, H. | +3

110

New use for an old drug : COX-independent anti-inflammatory effects of sulindac in models of cystic fibrosis

enthalten in: British journal of pharmacology | 2016

von Rocca, J. | Manin, S. | Hulin, A. | +7